Predictive value of eTag dimerization assay in patients with metastatic colorectal cancer treated with erlotinib.

被引：0
|
作者：
Oza, AM
Townsley, CA
Pond, G
Singh, S
Siu, LL
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Aclara Inc, Mountain View, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：865S / 865S
页数：1
相关论文
共 50 条
  • [31] Predictive markers for metastatic colorectal cancer
    Kjersem, Janne Beathe
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (07) : 647 - 647
  • [32] Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer
    Kozuch, Peter
    Malamud, Steve
    Wasserman, Carrie
    Homel, Peter
    Mirzoyev, Takhir
    Grossbard, Michael
    CLINICAL COLORECTAL CANCER, 2009, 8 (01) : 38 - 42
  • [33] Effect of renin-angiotensin system blockers on survival of metastatic non-small cell lung cancer patients receiving erlotinib.
    Aydiner, Adnan
    Ciftci, Rumeysa
    Sen, Fatma
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Prognostic and predictive value of circulating tumor cells in metastatic breast cancer patients treated with endocrine or chemotherapy
    Ellis, MJ
    Miller, MC
    Cristofanilli, M
    Budd, GT
    Stopeck, A
    Hayes, DF
    Doyle, GV
    Matera, J
    Terstappen, LWMM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S7 - S7
  • [35] Predictive value of serum MALDI-TOF proteomic profiling from patients treated with erlotinib and bevacizumab for survival in patients with non-small cell lung cancer (NSCLC) treated with erlotinib alone
    Dang, T. P.
    Salmon, J. S.
    Chen, H.
    Chen, S.
    Lee, J. W.
    Sandler, A. B.
    Herbst, R. S.
    Brahmer, J.
    Carbone, D. P.
    Shyr, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer
    Hecht, J. Randolph
    Patnaik, Amita
    Berlin, Jordan
    Venook, Alan
    Malik, Lmtiaz
    Tchekmedyian, Simon
    Navale, Lynn
    Amado, Rafael G.
    Meropol, Neal J.
    CANCER, 2007, 110 (05) : 980 - 988
  • [37] THE PREDICTIVE AND PROGNOSTIC VALUE OF YKL-40 IN KRAS WILD TYPE PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH THIRD-LINE CETUXIMAB AND IRINOTECAN
    Spindler, K. L. S.
    Vittrup, B. V.
    Christensen, I. C.
    Schou, J. S.
    Jakobsen, A. J.
    Hogdall, E. H.
    Pallisgaard, N. P.
    Nielsen, D. N.
    Johannesen, H. J.
    Johansen, J. H.
    ANNALS OF ONCOLOGY, 2010, 21 : I39 - I39
  • [38] Predictive Value of Increased Serum Procalcitonin in Patients with Colorectal Cancer
    Gourgiotis, Stavros
    Keramidaris, Dimitrios
    Veloudis, Georgios
    Oikonomou, Christianna N.
    Theodorolea, Kyriaki
    Villias, Constantinos A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E13 - E14
  • [39] PREDICTIVE VALUE OF CEA LEVELS IN 145 PATIENTS WITH COLORECTAL CANCER
    MCPHERSON, TA
    KOCH, M
    CLINICAL RESEARCH, 1977, 25 (05): : A710 - A710
  • [40] Identification of enterotype and its predictive value for patients with colorectal cancer
    Qingbo, Li
    Jing, Zhuang
    Zhanbo, Qu
    Jian, Chu
    Yifei, Song
    Yinhang, Wu
    Shuwen, Han
    GUT PATHOGENS, 2024, 16 (01)
12345